UK markets open in 1 hour 18 minutes
NIKKEI 225
28,502.51 +683.18 (+2.46%) HANG SENG
20,171.53 +89.10 (+0.44%) CRUDE OIL
93.96 -0.38 (-0.40%) GOLD FUTURES
1,806.80 -0.40 (-0.02%) DOW
33,336.67 +27.16 (+0.08%) BTC-GBP
19,655.26 -607.49 (-3.00%)
NVAX Sep 2022 210.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:26PM EDT. Market open.
| Previous close | 0.0100 |
| Open | 0.0100 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 210.00 |
| Expiry date | 2022-09-16 |
| Day's range | 0.0100 - 0.0100 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Simply Wall St.
These Analysts Just Made An Downgrade To Their Novavax, Inc. (NASDAQ:NVAX) EPS Forecasts
The latest analyst coverage could presage a bad day for Novavax, Inc. ( NASDAQ:NVAX ), with the analysts making...
- Zacks
Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y
Epizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates.
- Motley Fool
1 Reason to Sell Novavax Stock, and 1 Reason to Buy
This year hasn't been an easy one for Novavax (NASDAQ: NVAX) investors. After a series of stumbles culminating in its disastrous earnings report on Aug. 8, its shares are down by 60% so far in 2022. And with management slashing its full-year revenue guidance by roughly half, there isn't much hope for smoother sailing for at least a few quarters.
© 2022 Yahoo. All rights reserved.
